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Amyloid fibrils found in plaques in Alzheimer’s disease (AD) brains are com-
posed of amyloid-b peptides. Oligomeric amyloid-b 1-42 (Ab42) is thought to
play a critical role in neurodegeneration in AD. Here, we determine how size
and conformation affect neurotoxicity and internalisation of Ab42 assemblies
using biophysical methods, immunoblotting, toxicity assays and live-cell imag-
ing. We report significant cytotoxicity of Ab42 oligomers and their internali-
sation into neurons. In contrast, Ab42 fibrils show reduced internalisation and
no toxicity. Sonicating Ab42 fibrils generates species similar in size to oligo-
mers but remains nontoxic. The results suggest that Ab42 oligomers have
unique properties that underlie their neurotoxic potential. Furthermore, we
show that incubating cells with Ab42 oligomers for 24 h is sufficient to trig-
ger irreversible neurotoxicity.
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A key pathological hallmark of Alzheimer’s disease
(AD) is the deposition of extracellular amyloid pla-
ques in the brain [1]. Plaque deposits in AD brains
are composed of self-assembled forms of the amy-
loid-b (Ab) peptide arranged into cross-b amyloid
fibrils [2–4]. The Ab42 peptide isoform is one of the
primary components of these amyloid plaques. Ab42
self-assembly in vitro involves the formation of oli-
gomers, protofibrils and mature fibrils. This process
has been shown to occur via nucleated polymerisa-
tion, and intermediates are thought to be critical in
cytotoxicity [5–8]. Characterisation of each of these
assembled forms of Ab42 has been extensive. For
example, Bitan et. al. showed the preferential forma-
tion of Ab42 pentamer/hexamers in the initial stages
of oligomerisation which elongate to form protofib-
rils [9,10]. Protofibrils have been defined as being
prefibrillar, curvy linear assemblies < 200 nm in
length [11] that lead to formation of amyloid fibrils.
Mature amyloid fibrils are insoluble rod-like assem-
blies characterised by the cross-b structure, which is
attributed to the orientation of b-strands running
perpendicular to the fibre axis, with pairs of b-sheets
being tightly associated via interdigitating amino acid
side chains [12]. Cryo-electron microscopy (cryo-EM)
and solid-state nuclear magnetic resonance (ssNMR)
have provided atomic structures of Ab42 fibrils con-
firming a parallel, in-register cross-b structure char-
acteristic of amyloid [13–18]. Amyloid fibrils are
thought to play a role in AD due to the dystrophic
Abbreviations
AD, Alzheimer’s disease; Ab, amyloid-b; BME, b-mercaptoethanol; CD, circular dichroism; cryo-EM, cryo-electron microscopy; DMSO,
dimethyl sulfoxide; HRP, horseradish peroxidase; ssNMR, solid-state nuclear magnetic resonance; TEM, transmission electron microscopy.
1FEBS Letters (2020) ª 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
neurons, activated microglia and reactive astrocytes
surrounding plaque areas [19,20].
Small, prefibrillar oligomeric species of the Ab42
peptide have been identified as the primary culprits of
toxicity [2,21–23]. Focus on these assemblies has been
heavily influenced by the correlation between cognitive
decline and soluble Ab [23]. The term ‘oligomer’ cov-
ers a large range of sizes, leading to arguments for dif-
ferent sizes being more or less toxic than others.
Several Ab42 oligomeric assemblies have been identi-
fied as cytotoxic [2,5,24–31]. Ab42 oligomers have been
shown to cause receptor-mediated cytotoxicity [21],
permeation of biomimetic membranes [8,32,33],
changes in lysosomal pathways [34–37], disruption of
cellular homeostasis through intracellular accumula-
tion of Ab42 oligomers [38,39], and oxidative stress
induction and protein synthesis impairment [40]. Addi-
tionally, Ab fibrils have been implicated as reservoirs
of oligomers, facilitating further toxicity [23,41–43].
However, the properties that confer cytotoxicity and
the mechanisms by which they lead to neurodegenera-
tion have not been fully established.
Here, the importance of structure, size and assem-
bly state of Ab42 on toxicity and internalisation into
hippocampal neurons was assessed by comparing
Ab42 oligomers (AbO) [44] with mature (AbF) and
sonicated Ab42 fibrils (AbSon). AbO and AbF were
obtained by incubating monomeric Ab42 at room
temperature for 2 and 48 h, respectively. Sonication
of mature fibrils results in assemblies that approxi-
mately correspond to the size of oligomers and
protofibrils. We show that sonicated fibrils retain
structural characteristics of mature fibrils, whereas the
oligomer samples are in the early stages of self-assem-
bly. Only AbO were toxic and internalised signifi-
cantly more than AbSon or AbF. Our results suggest
that assembly size alone does not determine toxicity
and does not correlate directly with internalisation.
We propose that AbO have unique characteristics
that might enhance their ability to be internalised
and contribute to their toxicity. We have also identi-
fied a threshold of AbO exposure/internalisation after
which the cell can no longer recover and significant
oligomer-induced cytotoxicity is displayed.
Results
Sonication of fibrils results in species with a
similar size to oligomers, but a similar
conformation to fibrils
Ab42 peptide was pretreated to remove preaggregated
species and solvent contaminants then incubated for
2 h to generate oligomers or 48 h to produce a pre-
dominantly fibrillar sample. Oligomer preparation was
based on a previously optimised protocol [44]. The fib-
rillar sample was sonicated to produce small species,
referred to as oligomer-like, similar in size to AbO.
Although sonicated fibrils are unlikely to elongate by
primary nucleation due to a depleted pool of mono-
mer, sonication was carried out on ice to prevent the
possibility of further assembly by secondary nucleation
[45,46]. Fibrils were sonicated for 5, 10 and 20 min to
optimise the generation of oligomer-like species
(Fig. 1A. Five minutes was not sufficient to fragment
the fibrils, whereas by 20 min no species were present
by transmission electron microscopy (TEM; therefore,
10 min was selected as optimal. The particle sizes were
measured from TEM images and compared with oligo-
meric samples (AbO (Fig. 2A) that contained spherical
species with diameters ranging from 4.5 to 45 nm.
TEM of AbSon shows a distribution of small curvy
linear fibrils and small spherical species measuring
between 5 and 794 nm in length (n = 544) (Fig. 1B).
90% were ≤ 200 nm, and 50% were ≤ 45 nm. The
diameters of AbSon species ranged from 7 to 50.5 nm
(Fig. 1C). Comparisons of AbO with AbSon showed
both had a median diameter size of ~ 20 nm for both
oligomer and oligomer-like species formed by sonica-
tion (Fig. 1D). Combined, these results show that son-
icating Ab fibrils produces species that are comparable
in size to Ab oligomers.
Transmission electron microscopy was used to com-
pare oligomeric, fibrillar and sonicated fibril mor-
phologies (Fig. 2A). The conformation of AbO, AbF
and AbSon was investigated further using circular
dichroism (CD) in combination with western blotting.
The CD spectrum for AbO shows a minimum
at ~ 198 nm and a second shoulder at ~ 220 nm, sug-
gesting that the solution contains random coil confor-
mation with a contribution of b-sheet (Fig. 2B, blue
line). We have previously shown that freshly prepared
Ab1-42 is entirely random coil, that is with no signal
at 220 nm following dissolution and develops over-
time to show increasing b-sheet content [44]. AbF and
AbSon show similar spectra with minima at ~ 218 nm
and maxima at ~ 198 nm consistent with b-sheet struc-
ture (Fig. 2B, black and red lines, respectively). The
AbSon minimum has an increased intensity consistent
with increased solubility of the smaller species. This
suggests that at the secondary structural level, the oli-
gomeric sample is either a mixture of species in solu-
tion (unaggregated, monomeric peptide generating a
random coil signal and b-sheet-rich oligomers), or oli-
gomers that contain both random coil and b-sheet
conformation. Nevertheless, it is likely that the
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shoulder at ~ 220 nm is the result of oligomer forma-
tion, showing they do have some b-sheet content.
SDS/PAGE with western blotting using the anti-Ab
antibody 6E10 (Fig. 2C), which recognises the N-ter-
minal residues 4-10 of Ab [47], shows that AbO
migrates with bands with molecular weights corre-
sponding to monomeric, dimeric and trimeric species
with some higher molecular weight species consistent
with previous reports [44]. The majority of AbF is
found in the well with some higher molecular weight
species but showing no lower molecular weight bands.
AbSon migrates with a band distribution similar to
AbO showing monomeric, dimeric and trimeric spe-
cies but with higher molecular weight species and
some material in the well similar to AbF. This sug-
gests that the AbSon sample is representative of some
species similar in size to that of the oligomeric
sample.
AbO but not AbF or AbSon is cytotoxic following
internalisation
Next, we sought to examine the toxicity of the differ-
ent Ab42 assembly preparations. The ReadyProbes
live/dead assay was used to assess the effect of 10 lM
AbO, AbF and AbSon incubated with primary hip-
pocampal cultures for 72 h (Fig. 3). AbO displayed
43  2% cell death, whilst AbF and AbSon displayed
18  2% and 20  2% cell death, respectively. Only
the oligomeric preparation showed significant cell
death compared with buffer control. Previous studies
have shown that oligomeric Ab42 is internalised into
neuroblastoma cells and primary hippocampal neurons
[35,37,44,48–53], therefore, we compared the internali-
sation of the three Ab42 preparations to determine
whether the ability to be internalised was linked to














































































































































































































Fig. 1. Optimisation of Ab42 fibril
sonication (AbSon). (A) Ab42 fibres were
sonicated at the maximum setting for 5,
10 and 20 min on ice. 10 min of
sonication was selected as the optimal
time for the generation of oligomer-like
species (black arrow). Measurement and
quantification of the length (B) and
diameter (C) of oligomer-like Ab42-
sonicated fibres (n = 544) from TEM
images. (B) Lengths ranged from 5 nm to
794 nm, with 90% ≤200 nm and 50%
≤45 nm, the latter being the maximum
AbO diameter measured. (C) Diameters of
sonicated fibres ranged from 7 nm to
51 nm. (D) Box plot showing the range of
diameters in oligomer and oligomer-like
species (median for both = 20 nm). Scale
bar = 200 nm. 50 µM Ab42 was prepared
in 10 mM HEPES buffer pH 7.4 and
incubated for 48 h at room temperature to
obtain a predominantly fibrillar population
before sonication.
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dye that conjugates to amine groups [35,44], and the
Alexa Fluor 488-labelled AbO, AbF and AbSon were
incubated with neurons for up to 72 h and examined
using live-cell imaging after 4-, 24- and 72-h incuba-
tion times (Fig. 4). Green puncta were observed within
the cell body for all species after 4-h incubation
(Fig. 4A, white arrows), and there was no significant
difference between the fluorescence intensity in cells
treated with either AbO, AbF or AbSon, which have
mean intensities of 7  2, 6  4 and 7  3 AFU,
respectively (Fig. 4B). At 24 h, the mean fluorescence
intensity in cells treated with AbO increased to
14  8, compared with 10  4 for AbF and 14  9
AFU for AbSon. The difference between AbSon and
AbF is significant. After 72 h, the differences were
more pronounced and significantly different from one
another, with AbO showing a mean intensity of
31  13, AbF 10  7 and AbSon 18  13 AFU
(Fig. 4B). Although there is a significant difference in
fluorescence intensity of AbF and AbSon (Fig. 4B and
Fig. S1), there is a larger difference between AbO and
AbSon, suggesting that the uptake of sonicated fibrils
is less efficient than oligomers. The fluorescence inten-
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Fig. 2. (A) Negative stain transmission
electron micrographs for AbO, AbF and
AbSon. Small, spherical assemblies are
present in the oligomer preparation,
elongated fibrils in the fibrillar preparation
and sonicated fibrils contain short fibrils
and smaller species. Scale bars are
200 nm. (B) CD spectra for AbO, AbF and
AbSon. 50 lM Ab42 was incubated for 2 h
at room temperature for AbO, 48 h for
AbF, and these were sonicated on ice for
10 min for AbSon. AbO shows a random
coil signal (minimum at 198 nm), and
AbF and AbSon show a b-sheet signal
(minimum at 218 nm, maximum at
198 nm). Samples were prepared in
20 mM phosphate buffer pH 7.4 and
measured in a 1-mm pathlength cuvette.
Error bars expressed as  SEM, n = 3. (C)
Western blot of AbO, AbF and AbSon
samples using 6E10 to detect the size of
assemblies present in each sample. AbO
migrate as monomers (4.5 kDa), dimer/
trimers (9 kDa/13.5 kDa) and a smear of
higher molecular weight species. AbF
show no lower molecular weight species
with some fibrils stuck in the well of the
gel. AbSon show a mixture of all species
from monomers to fibrils. Samples were
prepared in 10 mM HEPES buffer pH 7.4.
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the cell continues to endocytose Ab42. The results
show that neurons preferentially take up oligomeric
Ab42 species but can also endocytose fibrillar and son-
icated fibrillar species to a lesser degree.
At least 24-hour incubation is required for AbO
toxicity
We have shown that AbO is more toxic and more read-
ily internalised than AbSon and AbF. To examine the
link between internalisation of AbO and the exposure
time required to result in toxicity, the ReadyProbes
assay was used to measure cell death after incubation
with AbO for 2, 4 or 24 h. AbO was removed from the
culture after the specified incubation period and replaced
with fresh, Ab-free media, thereby removing AbO from
the environment. Cell viability was measured 7 days
after initial incubation with AbO and presented as a per-
centage of dead cells in culture (Fig. 5). As the aim of
this experiment was to identify whether there is a thresh-
old of AbO exposure after which the cell can no longer
recover, this 7-day time point was chosen based on our
previously presented work where we have shown a much
more pronounced AbO-induced cytotoxicity compared
with 3 days. This ensured that any lack of significant
cytotoxicity after 3 days was not simply due to a slower
rate of cytotoxicity once AbO had been removed from
the cellular environment and replaced with fresh media.
The cytotoxicity of AbO incubated for the full 7 days
was 66  3%. Cells incubated for 2 or 4 h with AbO
before being replaced with fresh media displayed no sig-
nificant cytotoxicity compared with buffer incubated
cells, which also had a media change, at 7 days (18%
and 26%, respectively). Cells incubated with AbO for
24 h before being exchanged with fresh media displayed
significant toxicity at 7 days (~41  4%). Combining
this with the internalisation data, toxicity appears to cor-
relate with the amount of AbO internalised into the cell.
Four hours after adding to cells, only a relatively small
amount of AbO has been internalised, and there is no
toxic effect. AbO are toxic to cells only after incubation
at 24 h, when there are increased levels of AbO inside
the cell (Fig. 4A). Our findings suggest a threshold is
reached between 4 and 24 h, at which point the cells can
no longer recover from the amyloid insult. Removing
AbO after 2 and 4 h does not allow for this threshold
of internalisation to be reached, and no significant toxic-
ity is observed after 7 days.
Discussion
The work presented here aims to assess the importance
of size, structure and assembly state of Ab42 on
internalisation and neurotoxicity. We first charac-
terised the conformation and size of AbO, AbF and
AbSon. TEM allowed visualisation and measurement
of the different species. The ability of sonication to
produce species similar to oligomers has been previ-
ously shown for hen egg-white lysozyme [54] and the
prion protein [55] and has been used to investigate the
effect of fibril size on biological activity [56]. Although
there was some heterogeneity in length in the sonicated
fibril sample, the conditions used did generate approxi-
mately half the sample with species that had the same
dimensions as the oligomers, with a large majority
(90%) being within the range of what could be consid-
ered protofibrillar, that is 200 nm [11,57] or smaller.
Although the AbO sample displayed a predomi-
nantly random coil conformation by CD, this is likely
to arise from remaining monomer in solution dominat-
ing the spectra. The western blot shows a dominant
SDS-soluble monomer band, although it has been
shown that some oligomeric forms of Ab42 can be
broken down in the presence of SDS [58–60],
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Fig. 3. AbO, AbF and AbSon ReadyProbes cell viability assay. Rat
hippocampal cultures were treated with 10 µM AbO, AbF and
AbSon (prepared in 10 mM HEPES buffer pH 7.4) for 3 days
(n = 3). Cytotoxicity was measured as a percentage of dead cells
in a culture and compared with buffer incubated cells. AbO were
significantly toxic (43  2%, total number of cells = 1619, number
of dead cells = 703). AbF (18  2%, total number of cells = 783,
number of dead cells = 142) and AbSon (20  2%, total number of
cells = 425, number of dead cells = 83) showed no significant
cytotoxicity compared with buffer incubated cells (18  3%, total
number of cells = 1239, number of dead cells = 221). Unpaired
parametric Student’s t-test where P ≤ 0.01 (*), <0.001 (**), <0
(***). Error bars are expressed as  SEM.
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Fig. 4. Internalisation of Alexa Fluor 488-tagged AbO, AbF and AbSon in primary hippocampal rat neurons. 10 µM AbO, AbF and AbSon
were added to cells in culture and imaged at 4, 24 and 72 h. (A) Representative images of cells. Identical lookup tables have been applied
across all images. One 0.5-µm z-slice from the middle of the cell body is shown. Scale bar is 20 µm. White arrows indicate green
fluorescent intracellular puncta. (B) Quantification of 488 fluorescence intensity from at least three experiments per condition. n (cells) 4 h
AbO = 91, AbF = 63, AbSon = 77. 24 h AbO = 90, AbF = 40, AbSon = 62. 72 h AbO = 81, AbF = 56, AbSon = 50. Kruskal–Wallis one-way
ANOVA, with Dunn’s multiple comparison test. Only significant differences are shown, *P = 0.05, **P = 0.005, ****P = 0.0005.
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therefore, we do not consider this to be a quantifiable
representation of what is in the oligomeric sample.
The information provided by CD is an average of the
secondary structures within the sample and cannot dis-
tinguish between, for example, a sample of pure oligo-
mers with mostly random coil conformation and a
mixture of unfolded monomer and b-sheet-rich oligo-
mers. Although we cannot draw any conclusions as to
the structure of the oligomers using CD, we can infer
from several lines of evidence that they are likely to be
transitioning from random coil to a more b-sheet
structure. Firstly, there is a contribution of b-sheet in
the CD spectra. Secondly, as we have shown previ-
ously, this shoulder is not present in solutions of
freshly prepared, nonaggregated Ab42 and, impor-
tantly, the random coil minimum at 198 nm reduces as
aggregation and oligomer formation proceeds and as
monomer is depleted [44]. Finally, many groups have
reported that oligomeric species are b-sheet-rich struc-
tures [41,61,62]. Therefore, we propose that although
AbO shows a dominating random coil signal, this is
masking some b-sheet spectra. Both AbF and AbSon
display a similar b-sheet-rich conformation by CD.
However, only the sonicated fibrils show a wide size
range of assemblies detected by western blot, some of
which corresponded to the size of AbO. While we do
not know the exact conformation of the different oli-
gomeric species revealed by western blot or TEM, we
can be confident that by sonicating fibrils we have gen-
erated species that are a similar size to oligomers that
are not present in the AbF sample, as well as some
smaller and larger species.
Fragmented Ab42 fibrils might be expected to retain
the cross-b structure present in the mature fibril [63],
whereas oligomers formed at early stages of assembly
may have a different b-sheet-rich conformation. There
is a large body of evidence supporting the formation
of b-sheet-rich oligomers and these being structurally
distinct from mature fibrils. NMR spectroscopy has
shown that neurotoxic oligomers consist of loosely
aggregated b-strands arranged as a pentamer that do
not have the same b-sheet structure contained within
fibrils [58]). ssNMR has revealed oligomers with paral-
lel b-sheets [64,65] and hexameric b-barrels [66]. The
formation of b-sheet-rich pore-forming oligomers has
also been extensively reported which are folded differ-
ently to the cross-b structure of mature amyloid fibrils
[67–69]. Furthermore, previous studies have shown a
large overlap in the sizes of prefibrillar and fibrillar oli-
gomers [41], suggesting that distinct conformations of
the same size exist [70]. In line with this idea, our data
suggest that the sonicated oligomer-like species and
protofibrils generated by sonication have a high b-
sheet content that is most likely structurally similar to
mature fibrils. On the other hand, AbO will be more
structurally dynamic and still in the process of elonga-
tion, so while they most likely contain b-sheet struc-
ture it could be distinct to the AbF and AbSon
structure. This therefore allows us to test the effects of
conformation, size and self-assembly propensity on
internalisation and cellular health.
Measuring the cytotoxicity of each species confirmed
only AbO were significantly toxic after 3 days, while
AbF and AbSon showed no significant cytotoxicity.
As around 50% of the AbSon sample is species similar
in size to AbO, we might have expected to see at least
some toxic effect from the AbSon sample if toxicity
were solely mediated by oligomer size. In contrast with





















Fig. 5. Cytotoxicity of internalised AbO. Rat hippocampal cultures
were treated with 10 µM AbO (prepared in 10 mM HEPES buffer
pH 7.4) for 2, 4 or 24 h before being removed and replaced with
Ab-free media. Cells were then incubated up to 7 days and then
cytotoxicity measured using the ReadyProbes cell viability assay,
expressed as a percentage of dead cells and compared with buffer
incubated cells, which also had a media change. The percentage of
dead cells in buffer control was 16  2% (total number of
cell = 1152, number of dead cells = 180). AbO were significantly
toxic (66  3%, total number of cells = 1172, number of dead
cells = 777) at 7 days. Cells incubated with AbO for 2 and 4 h
displayed no significant cytotoxicity at 7 days (18  2%, total
number of cells = 595, number of dead cells = 105 and 26  3%,
total number of cells = 599, number of dead cells = 154,
respectively). Cells incubated with AbO for 24 h displayed
significant cytotoxicity at 7 days (41  4%, total number of
cells = 602, number of dead cells = 249). Unpaired parametric
Student’s t-test where P ≤ 0.01 (*), < 0.001 (**), < 0 (***). Error
bars are expressed as  SEM (n = 3).
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previously demonstrated that shortened amyloid fibril
length correlates with reduced cellular health [56].
Fragmented amyloid fibrils of b2-microglobulin, lyso-
zyme and a-synuclein proteins showed increased ability
to affect membrane integrity and overall cell viability,
likely due to an increased number of toxic fibril–mem-
brane interactions. Their study also highlights the dif-
ferential response of three cell lines to mature or
fragmented fibrils. It is possible that different concen-
trations and/or incubation times are required in pri-
mary neurons to observe similar cellular dysfunction.
Therefore, while cytotoxicity may to some extent
depend on the physical properties (e.g. length and
width) of an amyloid aggregate, our results show that
many other factors including peptide precursor (which
would in turn determine the molecular structure), cell
type and readout of cell viability are all contributing
factors in determining the toxic potential of amyloid
aggregates in vitro. The significant Ab42 oligomer-in-
duced cytotoxicity compared with that displayed by
fibrillar Ab42 has been previously demonstrated [71–
75]. Furthermore, the presence of dimers and trimers
in both AbO and AbSon, which are likely to be similar
assemblies, suggests that these alone are not sufficient
to cause cytotoxicity as assessed in the timeframe of
our experiments. We have shown in previous work
that an assembly impaired variant of Ab42 (F20A,
G37D) that remains monomeric does not affect cell
viability [44], in line with studies showing that the less
aggregation-prone Ab40 isoform is significantly less
toxic than Ab42 [73].
We and others have previously shown that oligo-
meric Ab42 is internalised into cells [35,37,44,48,49,51–
53]. To study whether this may be linked to toxicity,
we examined the internalisation of the different species
into primary hippocampal neurons and found that at
three days, where we know AbO to be toxic, there was
significantly more internalisation than either AbF or
AbSon. There is least uptake from the AbF sample
and no toxicity, suggesting that smaller species are
more readily internalised and that this process leads
eventually to cell death. The internalisation of AbSon
species was greater than fibrils, perhaps due to an
increased number of fibril ends and therefore fibril–
membrane interactions that may lead to enhanced
internalisation [56,76]. These results indicate a possible
correlation between the amount of internalisation and
toxicity. Various studies have suggested a link between
the accumulation of intracellular Ab and neuronal
pathology [77–79] although further work is needed to
establish a causative link between internalisation and
cytotoxicity. Furthermore, we show that oligomers are
only toxic after they have been incubated with cells for
24 h and that this effect can be prevented if oligomers
are removed before this time. This is consistent with
our recently published work showing significant levels
of AbO toxicity in hippocampal neurons assessed after
24-hour incubation at the same concentration [35].
Toxicity assessed at 24 h of AbO incubation was
roughly half of that seen here where we have removed
AbO after 24 h and assessed cytotoxicity at day 7 after
initial oligomer addition. This suggests that the down-
stream effects continue to occur and cause further
cytotoxicity even if oligomers are removed from the
extracellular environment. Increasingly significant
levels of AbO toxicity at 3 and 7 days have also been
shown with incubated hippocampal neurons, further
supporting the idea that longer oligomer exposure
leads to higher toxicity [35,44]. It has been proposed
that there is a threshold of oligomer internalisation
after which the cell is unable to efficiently clear or
degrade Ab [80] and therefore no longer recover.
Therefore, it is conceivable that if sufficient amounts
of AbSon were able to be endocytosed, or if they were
left on the cell for long enough, they might also be
toxic.
The reduced internalisation of AbSon compared
with AbO may explain why the species are not toxic,
but why do they show such a significantly reduced
uptake? It might be that the reduced internalisation is
due to a lower concentration of oligomers of a particu-
lar size that are more abundant in the AbO sample.
However, this seems unlikely as the majority of species
(90%) in the AbSon sample are up to a maximum of
200 nm in length, much shorter than their parent fib-
rils, which are of indeterminate length in the range of
microns. Particle size has shown to be an important
determinant in endocytosis with a limit of 200 nm for
clathrin-mediated pathways [81,82]. Therefore, it is fea-
sible that comparable levels of AbSon and AbO could
be internalised by the cell if the process was solely
based on size. Our data clearly show that neurons are
able to endocytose assemblies of any size, but to very
different extents. Although there were no low molecu-
lar weight oligomers in the AbF sample, there was still
some uptake. This could be endocytosis of full-length
fibrils, fibrils fragmented once inside the cell possibly
by the cell membrane, or uptake of oligomers that
have dissociated from fibril ends [83]. Previous studies
have shown that Ab oligomers interact with and dis-
rupt membrane bilayers differently to monomer or
fibres. Oligomers extract lipids from the membrane in
a detergent-like manner, whereas fibres embed within
the bilayer [84]. In addition, only oligomers of Ab42
and not Ab40 are able to form ion channels [85]. Simi-
larly, the oligomers used in our experiments may have
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unique characteristics that make them more amenable
to internalisation and more toxic. For example,
hydrophobic regions are exposed in oligomers, which
have been shown to affect the affinity with which
Ab42 oligomers bind to cellular membranes [86,87]. In
contrast, mature fibrils, and most likely the sonicated
species we have generated, are highly ordered and
stable with the majority of their hydrophobic surfaces
buried within the fibre.
Together, our data strongly suggest that conforma-
tion and potential for self-assembly rather than size
influence AbO-mediated internalisation and neurotoxi-
city. Despite sharing a similar size to AbO, AbSon are
not as readily internalised and are not toxic. Oligomers
have a propensity for further self-assembly into mature
fibrils using available monomers for elongation,
whereas fibrils and sonicated fibrils are already mostly
fully assembled. We propose that AbO are more toxic
because they are endocytosed more efficiently, and this
in turn is dictated by two characteristics: (1) they are
structurally distinct from fibrils and sonicated fibrils
and (2) oligomers are in a more dynamic state and are
continuing to self-assemble. We also show that the
toxic effects of AbO are triggered by incubation with
cells for only 24 h. These results contribute to our






chased from rPeptide (CAT# A-1163-2) as 1,1,1,3,3,3-hex-
afluoro-2-propanol (HFIP) films (>97% purity) with a
confirmed molecular mass of 4514.3 Da. 0.2 mg aliquots of
peptide were solubilised in 200 µL HFIP (Merck Life
Science UK, Dorset, UK) to dissolve any preformed aggre-
gates. The solution was vortexed for 1 min and sonicated
in a 50/60Hz bath sonicator for 5 min. HFIP was dried off
using a steady flow of nitrogen gas, and then, 200 ll of
anhydrous dimethyl sulfoxide (DMSO) (Merck Life
Science) added and vortexed for 1 min. The solution was
sonicated for 1 minute and eluted through a buffer equili-
brated 7K MWCO Zeba buffer-exchange column (Thermo
Fisher Scientific, Hemel Hempstead, UK) at 4 °C. The pro-
tein solution was kept on ice, whilst the absorbance at
280 nm was measured using a NanoDrop spectrophotome-
ter. The concentration was calculated using a molecular
coefficient of 1490 M-1cm-1; (A280/1490) 9 106. Solutions
were immediately diluted to 50 lM in buffer, and this was
taken to be the new working stock. The solution was
incubated at room temperature for 2 h for AbO and at
room temperature for 48 h for AbF. For AbSon, the solu-
tion was incubated at room temperature for 48 h followed
by sonication for 10 min on ice. Solutions were prepared in
either HEPES buffer (10 mM HEPES, 50 mM NaCl,
1.6 mM KCl, 2 mM MgCl, and 3.5 mM CaCl2) or 20 mM
phosphate buffer (200 mM Na2HPO4, 200 mM NaH2PO4,
diluted to 20 mM with ddH2O), both at pH 7.4.
Preparation of Alexa Fluor 488-conjugated Ab
Ab42 was prepared as described above up to the addition
of DMSO. As per the manufacturer’s instructions (Life
Technologies, Thermo Fisher Scientific), the Alexa Fluor
488 tag was prepared by adding 10 µL H2O to an Alex
Fluor TFP ester (kept on ice). This was added to Ab42 in
DMSO with 10 µL 1 M sodium bicarbonate (pH 8.3) and
incubated at room temperature for 15 min. From this step
onwards, the sample was protected from light using alu-
minium foil. After this, the usual Ab preparation method
continued with the Zeba buffer-exchange column. To take
into account the absorbance of the dye, the following cal-
culation was used for the concentration of the 488-tagged
Ab42 preparation:
Protein concentration (M) = [A280 – (A494 x 0.11)]/
1490.
For 488-AbO, the solution was incubated for 2 h at
room temperature before being added to cells. The prepara-
tion was incubated for 48 h at room temperature for 488-
AbF, and for 488-AbSon, 488-AbF were sonicated on ice
for 10 min.
Transmission electron microscopy
4ll of peptide sample was applied to the surface of form-
var/carbon film-coated 400-mesh copper grids (Agar Scien-
tific) and allowed to adsorb for 2 min before being blotted
dry. The grid was then washed with 4 lL of Milli-Q-filtered
water and blotted dry and negatively stained using 2% (w/v)
uranyl acetate for 2 min, blotted and then dried. This was
repeated once more, and the grid was left to air dry before
being imaged. All grids were examined and imaged using a
JEOL JEM1400-Plus TEM at 120 kV, and images were cap-
tured using a Gatan OneView 4K camera (Abingdon, UK).
FIJI software was used to measure the length of oligomers
and sonicated fibrils; three images from three independent
preparations were measured.
Circular dichroism
Aliquots of peptide samples (prepared in 20 mM phosphate
buffer, pH 7.4) were placed in a 1-mm pathlength quartz
cuvette (Hellma). Scans were taken between 180 and 280 nm
on a JASCO J715 Spectropolarimeter at 20°C. Three spectra
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were averaged for each measurement. Spectral data were
converted to molar ellipticity using the following equation:
Mdeg x Molecular Weight/ (10 9 mgml1 9 pathlength of
cuvette 9 number of amino acids).
Western blotting
About 2 lg of Ab42 in 4 9 Laemmli sample buffer (Bio-
Rad) containing 1:10 b-mercaptoethanol (BME) was loaded
on a 50 lL 10-well 4-20% Mini-PROTEAN TGX Stain-Free
gel (Bio-Rad). The gel was run in 1X running buffer (diluted
from 10X Tris/Glycine/SDS stock, Bio-Rad) at 100 V. The
gel was then transferred on to 0.45-lm nitrocellulose mem-
brane in 1X transfer buffer (diluted from 10X Tris/Glycine
stock, Bio-Rad) for 2 h at 25 V. The membrane was incu-
bated with blocking buffer (10% milk in Tris-buffered saline
with 0.1% Tween (TBS-T)) at room temperature for 1 h
after which 6E10 primary antibody (BioLegend) (1:10,000
dilution in blocking buffer) was applied for overnight at 4°C.
The membrane was washed three times with 0.1% TBS-T for
10 min per wash after which the membrane was incubated
with horseradish peroxidase (HRP) conjugated anti-mouse
secondary antibody (Cell Signalling) (1 : 10 000 dilution in
blocking buffer) for 30 min at room temperature. The mem-
brane was washed again three times with 0.1% TBS-T before
being incubated with enhanced chemiluminescence (ECL)
substrate for 5 minutes. The membrane was developed on
CL-Exposure Film (Thermo Fisher).
Cell culture
Rats are housed in a specialised facility under Home Office
guidelines and sacrificed using Schedule 1 procedures in
accordance with Animals (Scientific Procedures) Act 1986,
Amendment Regulations 2012. Primary hippocampal cultures
were prepared from either P0 or P1 rats. Initially, the hip-
pocampus was dissected in ice-cold Hanks’ Balanced Salt
Solution (HBSS) containing 0.1 M HEPES. It was then
washed in prewarmed basal medium eagle (BME) (Gibco)
containing 0.5% glucose, 2% fetal bovine serum (FBS),
1 mM Na-pyruvate, 0.01 M HEPES (pH 7.35), penicillin/
streptomycin, 1% B27 supplement and 1% GlutaMAX. The
hippocampus was titrated using a 1-ml pipette until the tissue
was fully dissociated and finally diluted further with the
BME-supplemented media. Approximately 40,000 cells were
plated on poly-D-lysine (20 lgmL-1) and laminin (20 lgmL-
1) precoated coverslips and incubated at 37 °C and 5% CO2.
After 3-5 days of incubation, the cells were treated with
3.25 lM cytosine arabinoside to stop astrocyte proliferation.
Cells were used in experiments 10-14 days after plating.
ReadyProbes cell viability assay
Ab42 was prepared in 10 mM HEPES as described above
and incubated at room temperature for 2 hours for AbO,
48 hours for AbF, and fibres were sonicated for 10 minutes
on ice for AbSon. Each preparation was incubated with rat
primary hippocampal cultures at a final concentration of
10 lM. After incubation with the peptide for the required
amount of time, one drop of each ReadyProbes reagent
(Life Technologies) was added to the wells. The NucBlue
live reagent (excitation/emission at 360 and 460 nm, respec-
tively) stains the nuclei of all cells. The NucGreen dead
reagent (excitation/emission at 504 and 523 nm, respec-
tively) stains only the nuclei of dead cells with compro-
mised plasma membranes. Cells were incubated for
15 minutes with the reagents and then imaged using a Zeiss
CO widefield microscope using the DAPI and FITC filters.
4-6 regions of interest were imaged per well, and the per-
centage of dead cells was calculated as the number of green
cells in the entire blue-stained population. Astrocytes in the
cultures were not counted. The experiment was repeated 3
independent times.
For experiments testing whether AbO internalisation is
necessary to mediate cytotoxicity, cells were treated with
10 µM AbO for increasing lengths of time before being
replaced with fresh, Ab-free media. Cells were incubated
for a total of 7 days before using the ReadyProbes assay to
measure cytotoxicity.
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